This review highlights advanced biologics and innovative delivery systems for treating inflammatory bowel disease, suggesting improved patient outcomes.
Key Points
Novel treatments for inflammatory bowel disease are emerging, aiming to improve treatment efficacy and reduce side effects.
Advanced options like biologics, microbiome interventions, and drug delivery systems enhance bioavailability in patients.
Combining conventional and novel therapies may leverage synergistic effects for better disease management.
Significant challenges remain in integrating technological advancements like AI and telemedicine into IBD treatment strategies.